HCPCS Level IIdrugActive
J7356
Inj foscarb/foslevodopa 5 mg
BETOS: O1E
Effective: 2025-07-01
Referenced in 2 policies
Description
Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vyalev
Manufacturer
AbbVie Inc.
HCPCS Dosage
0.25 MG - 5 MG
Billing Units
480.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.